Assessment of melanoma follow-up trends in medicare patients

A large scale, multi-regional analysis

Osama Hashmi, Jennifer L Waller, Jake E. Turrentine

Research output: Contribution to journalArticle

Abstract

Background: Research on patient follow-up compliance after a diagnosis of melanoma has been limited. Objective: To assess the timelines for follow-up among patients who are diagnosed with melanoma and to assess the socioeconomic and provider factors which influence follow-up adherence. Methods: A retrospective, population-based study using nationally representative data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database was conducted to evaluate 10,813 patients who were diagnosed with melanoma from 2005-2013. Results: We found that 97% of the individuals with melanoma had at least one follow-up visit, with 80.5% having their first follow-up visit within the first 6 months and 88.6% having their first follow-up visit within 12 months. Patients who had a dermatologist as the diagnosing provider were significantly more likely to follow up. Additionally, patients who returned were more likely to live in a community with a higher socioeconomic status. Limitations: Applicability of the data to a non-Medicare population and confounding variables such as co-morbid conditions are limitations. Conclusions: The majority of patients diagnosed with melanoma follow up with a provider within one year. However, socioeconomic and provider factors play important roles in influencing patient return visits.

Original languageEnglish (US)
Article number4
JournalDermatology Online Journal
Volume24
Issue number8
StatePublished - Aug 1 2018

Fingerprint

Medicare
Melanoma
Confounding Factors (Epidemiology)
Social Class
Population
Epidemiology
Databases
Research

Keywords

  • Follow-up
  • Melanoma
  • Seer

ASJC Scopus subject areas

  • Dermatology

Cite this

Assessment of melanoma follow-up trends in medicare patients : A large scale, multi-regional analysis. / Hashmi, Osama; Waller, Jennifer L; Turrentine, Jake E.

In: Dermatology Online Journal, Vol. 24, No. 8, 4, 01.08.2018.

Research output: Contribution to journalArticle

@article{04b542830635412d887bb2ccf1ae5175,
title = "Assessment of melanoma follow-up trends in medicare patients: A large scale, multi-regional analysis",
abstract = "Background: Research on patient follow-up compliance after a diagnosis of melanoma has been limited. Objective: To assess the timelines for follow-up among patients who are diagnosed with melanoma and to assess the socioeconomic and provider factors which influence follow-up adherence. Methods: A retrospective, population-based study using nationally representative data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database was conducted to evaluate 10,813 patients who were diagnosed with melanoma from 2005-2013. Results: We found that 97{\%} of the individuals with melanoma had at least one follow-up visit, with 80.5{\%} having their first follow-up visit within the first 6 months and 88.6{\%} having their first follow-up visit within 12 months. Patients who had a dermatologist as the diagnosing provider were significantly more likely to follow up. Additionally, patients who returned were more likely to live in a community with a higher socioeconomic status. Limitations: Applicability of the data to a non-Medicare population and confounding variables such as co-morbid conditions are limitations. Conclusions: The majority of patients diagnosed with melanoma follow up with a provider within one year. However, socioeconomic and provider factors play important roles in influencing patient return visits.",
keywords = "Follow-up, Melanoma, Seer",
author = "Osama Hashmi and Waller, {Jennifer L} and Turrentine, {Jake E.}",
year = "2018",
month = "8",
day = "1",
language = "English (US)",
volume = "24",
journal = "Dermatology Online Journal",
issn = "1087-2108",
publisher = "Department of Dermatology UC Davis",
number = "8",

}

TY - JOUR

T1 - Assessment of melanoma follow-up trends in medicare patients

T2 - A large scale, multi-regional analysis

AU - Hashmi, Osama

AU - Waller, Jennifer L

AU - Turrentine, Jake E.

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Background: Research on patient follow-up compliance after a diagnosis of melanoma has been limited. Objective: To assess the timelines for follow-up among patients who are diagnosed with melanoma and to assess the socioeconomic and provider factors which influence follow-up adherence. Methods: A retrospective, population-based study using nationally representative data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database was conducted to evaluate 10,813 patients who were diagnosed with melanoma from 2005-2013. Results: We found that 97% of the individuals with melanoma had at least one follow-up visit, with 80.5% having their first follow-up visit within the first 6 months and 88.6% having their first follow-up visit within 12 months. Patients who had a dermatologist as the diagnosing provider were significantly more likely to follow up. Additionally, patients who returned were more likely to live in a community with a higher socioeconomic status. Limitations: Applicability of the data to a non-Medicare population and confounding variables such as co-morbid conditions are limitations. Conclusions: The majority of patients diagnosed with melanoma follow up with a provider within one year. However, socioeconomic and provider factors play important roles in influencing patient return visits.

AB - Background: Research on patient follow-up compliance after a diagnosis of melanoma has been limited. Objective: To assess the timelines for follow-up among patients who are diagnosed with melanoma and to assess the socioeconomic and provider factors which influence follow-up adherence. Methods: A retrospective, population-based study using nationally representative data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database was conducted to evaluate 10,813 patients who were diagnosed with melanoma from 2005-2013. Results: We found that 97% of the individuals with melanoma had at least one follow-up visit, with 80.5% having their first follow-up visit within the first 6 months and 88.6% having their first follow-up visit within 12 months. Patients who had a dermatologist as the diagnosing provider were significantly more likely to follow up. Additionally, patients who returned were more likely to live in a community with a higher socioeconomic status. Limitations: Applicability of the data to a non-Medicare population and confounding variables such as co-morbid conditions are limitations. Conclusions: The majority of patients diagnosed with melanoma follow up with a provider within one year. However, socioeconomic and provider factors play important roles in influencing patient return visits.

KW - Follow-up

KW - Melanoma

KW - Seer

UR - http://www.scopus.com/inward/record.url?scp=85055278718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055278718&partnerID=8YFLogxK

M3 - Article

VL - 24

JO - Dermatology Online Journal

JF - Dermatology Online Journal

SN - 1087-2108

IS - 8

M1 - 4

ER -